Perspectives on breast reconstruction following mastectomy vary among patients

Less than 42% of women underwent breast reconstruction following a mastectomy for cancer, and the factors associated with foregoing reconstruction included being black, having a lower education level, and being older.

Insurance coverage for breast reconstruction following a mastectomy has been guaranteed since the Women's Health and Cancer Rights Act in 1998. Still, most women who undergo a mastectomy do not have breast reconstruction surgery. Little is known about patient attitudes regarding reconstruction.

The research team, led by Monica Morrow, MD, of the Memorial Sloan Kettering Cancer Center in New York, New York, used Surveillance, Epidemiology and End Results (SEER) registries from Los Angeles and Detroit to identify women (age 20 to 79 years) with specific types of breast cancer. Eligible women were asked to complete a survey. The analytic sample for the authors' study included 485 patients who initially reported undergoing a mastectomy and four years later reported remaining disease free.      

Of the 485 women who had a mastectomy, 24.8% underwent immediate breast reconstruction and 16.8% had delayed reconstruction (total, 41.6%). 

Common reasons for not undergoing reconstruction among women of all racial/ethnic groups were the desire to avoid additional surgery (48.5%) or feeling that reconstruction was not important (33.8%). Another reason was a fear of breast implants (36.3%).

Factors associated with not undergoing reconstruction were being black, a lower education level, being older, having a major coexisting illness, and chemotherapy. Some women (23.9%) were concerned about reconstruction and interference with the detection of later cancer.  Most women were satisfied with the decision-making process about whether to undergo reconstruction

“Our study suggests that room exists for improved education regarding the safety of breast implants and the effect of reconstruction on follow-up surveillance, information about which could be readily addressed through decision tools. Finally, development of specific approaches to address patient-level and systems factors with a negative effect on the use of reconstruction among minority women is needed,” stated the authors. The study was published in JAMA Surgery (2014; doi:10.1001/jamasurg.2014.548).

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs